Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|April 1, 2024
The occurrence of immune-related adverse events is an independent risk factor both for serum HBsAg increase and HBV reactivation in HBsAg-positive cancer patients receiving PD-1 inhibitor combinational therapyYingfu Zeng, Jiwei Huang, Jiahui Pang, et al.
Clinical Drug Investigation|March 20, 2016
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B PatientsMingxing Huang, Yusheng Jie, Guoli Lin, et al.
Ultrasound in Medicine & Biology|July 14, 2023
An Optimal Prognostic Model Based on Multiparameter Ultrasound for Acute-on-Chronic Liver FailureLili Wu, Yuankai Wu, Jieyang Jin, et al.
Frontiers in Cellular and Infection Microbiology|November 17, 2022
An early novel prognostic model for predicting 80-day survival of patients with COVID-19Yaqiong Chen, Jiao Gong, Guowei He, et al.
Plos One|June 2, 2017
Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosisZhanyi Li, Bingliang Lin, Guoli Lin, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2021
Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis BQi Zheng, Biyao Zou, Yuankai Wu, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 20, 2024
Association of moderate alcohol intake with the risks of cirrhosis and steatotic liver disease: Results from a large population-based cohort studyHongliang Xue, Liqing Wang, Yuankai Wu, et al.
International Journal of Clinical and Experimental Medicine|February 18, 2016
Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapyXiangyong Li, Yusheng Jie, Xu You, et al.
Annals of Translational Medicine|September 17, 2021
Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosisYanting Luo, Bingyuan Wu, Yuankai Wu, et al.
International Journal of Medical Sciences|March 9, 2013
Efficacy of entecavir treatment for up to 5 years in nucleos(t)ide-naïve chronic hepatitis B patients in real lifeJie Luo, Xiangyong Li, Yuankai Wu, et al.
Pageof 6